{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/647732f050150f001123b38e/68346da19a83db74bfa0734c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Meslinger - den lille sykdom?","description":"<p>Meslinger har vært en fryktet og hyppig forekommende sykdom opp gjennom historien. I moderne tid og med effektiv vaksine falt forekomsten – men i senere år har man sett stadig flere tilfeller (og utbrudd), inkludert i Europa og USA. Ingrid, Jørgen og Nikolai snakker seg gjennom meslinger «fra tidenes morgen» og frem til i dag. Bli med på reisen!</p><p><br></p><p>Og - for infeksjonsmedisinsk helsepersonell som lytter til episoden våren 2025 - her er lenke til påmelding NSCMID: <a href=\"https://www.nscmid2025.fi/\" rel=\"noopener noreferrer\" target=\"_blank\">Home - NSCMID 2025</a>.</p><p><br></p><p><strong>Referanser:</strong></p><p>1.&nbsp;Roald Dahl, 1986: “Measles: A dangerous disease” (open letter to parents).</p><p>2.&nbsp;Hübschen JM, et al. Measles. Lancet. 2022;399(10325):678-90.</p><p>3.&nbsp;Berche P. History of measles. Presse Med. 2022;51(3):104149.</p><p>4.&nbsp;Petrova VN, et al.&nbsp;Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles.&nbsp;Sci Immunol. 2019;4(41).</p><p>5.&nbsp;Mina MJ, et al.&nbsp;Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens.&nbsp;Science. 2019;366(6465):599-606.</p><p>6.&nbsp;Belongia EA, Naleway AL. Smallpox vaccine: the good, the bad, and the ugly.&nbsp;Clin Med Res. 2003;1(2):87-92.</p><p>8.&nbsp;Madsen KM, et al. A population-based study of measles, mumps, and rubella vaccination and autism.&nbsp;N Engl J Med. 2002;347(19):1477-82.</p><p>10.Holzmann H, et al.&nbsp;Eradication of measles: remaining challenges.&nbsp;Med Microbiol Immunol. 2016;205(3):201-8.</p><p>11.Jafri SK, et al. Subacute sclerosing panencephalitis - current perspectives.&nbsp;Pediatric Health Med Ther. 2018;9:67-71.</p><p>12.&nbsp;de Swart RL, et al. Rinderpest eradication: lessons for measles eradication?&nbsp;Curr Opin Virol. 2012;2(3):330-4.</p><p>13.Kim TH, et al. Vaccine herd effect. Scand J Infect Dis. 2011;43(9):683-9.</p><p>14.Doll MK, Correira JW. Revisiting the 2014-15 Disneyland measles outbreak and its influence on pediatric vaccinations.&nbsp;Hum Vaccin Immunother. 2021;17(11):4210-5.</p><p>13.Nuwarda RF, et al. Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines (Basel). 2022;10(10).</p><p>16.Minta AA, Ferrari M, Antoni S, et al.&nbsp;Progress Toward Measles Elimination — Worldwide, 2000–2023. MMWR Morb Mortal Wkly Rep 2024;73:1036–1042.</p><p>17.State School Immunization Requirements and Vaccine Exemption Laws, CDC 2022,State School Immunization Requirements and Vaccine Exemption Laws</p><p>18.Epidemiologi meslinger UK og Europa:&nbsp;<a href=\"https://www.gov.uk/government/publications/measles-epidemiology-2023\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.gov.uk/government/publications/measles-epidemiology-2023</a>,&nbsp;<a href=\"https://www.unicef.org/press-releases/european-region-reports-highest-number-measles-cases-more-25-years-unicef-whoeurope\" rel=\"noopener noreferrer\" target=\"_blank\">European Region reports highest number of measles cases in more than 25 years – UNICEF, WHO/Europe</a></p>","author_name":"Helse Bergen"}